HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abha Sahni Selected Research

Spotted Fever Group Rickettsiosis (Rickettsialpox)

9/2020Activation of Mechanistic Target of Rapamycin (mTOR) in Human Endothelial Cells Infected with Pathogenic Spotted Fever Group Rickettsiae.
1/2020Evolution, purification, and characterization of RC0497: a peptidoglycan amidase from the prototypical spotted fever species Rickettsia conorii.
1/2017Fibroblast growth factor receptor-1 mediates internalization of pathogenic spotted fever rickettsiae into host endothelium.
7/2012Regulation of inducible heme oxygenase and cyclooxygenase isozymes in a mouse model of spotted fever group rickettsiosis.
9/2006Infection of human endothelial cells with spotted Fever group rickettsiae stimulates cyclooxygenase 2 expression and release of vasoactive prostaglandins.
12/2005Potential roles for regulatory oxygenases in rickettsial pathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abha Sahni Research Topics

Disease

17Infections
03/2022 - 08/2002
6Spotted Fever Group Rickettsiosis (Rickettsialpox)
09/2020 - 12/2005
5Rickettsia Infections
03/2022 - 10/2013
4Rocky Mountain Spotted Fever (Sao Paulo Typhus)
03/2021 - 08/2002
4Inflammation (Inflammations)
09/2020 - 07/2004
3Boutonneuse Fever (Mediterranean Spotted Fever)
01/2019 - 12/2011
1Hypersensitivity (Allergy)
01/2018
1Sepsis (Septicemia)
01/2017
1Septic Shock (Toxic Shock Syndrome)
01/2017
1Hypertrophy
02/2010
1Lymphatic Metastasis
08/2009
1Neoplasms (Cancer)
08/2009
1Cardiovascular Diseases (Cardiovascular Disease)
08/2009
1Breast Neoplasms (Breast Cancer)
08/2009
1Neointima
01/2009
1Vascular System Injuries
01/2009

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
03/2021 - 08/2002
5CytokinesIBA
03/2021 - 07/2004
5Messenger RNA (mRNA)IBA
03/2021 - 08/2002
4RNA (Ribonucleic Acid)IBA
01/2019 - 01/2016
4AntioxidantsIBA
07/2012 - 08/2002
4EnzymesIBA
07/2012 - 08/2002
3ChemokinesIBA
03/2021 - 12/2011
3Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
07/2012 - 12/2005
2Small Interfering RNA (siRNA)IBA
09/2020 - 02/2010
2MicroRNAs (MicroRNA)IBA
12/2018 - 07/2017
2Long Noncoding RNAIBA
01/2018 - 01/2017
2IsoenzymesIBA
07/2012 - 12/2005
2Heme Oxygenase-1IBA
07/2012 - 08/2002
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2012 - 01/2009
2FibrinIBA
08/2009 - 07/2004
2Protein Isoforms (Isoforms)IBA
09/2006 - 12/2005
1bis(3',5')-cyclic diguanylic acidIBA
03/2022
1N,N'- dipyridoxylethylenediamine- N,N'- diacetic acid (PLED)IBA
03/2022
1Chemokine CX3CL1IBA
03/2021
1Mechanistic Target of Rapamycin Complex 2IBA
09/2020
1Mechanistic Target of Rapamycin Complex 1IBA
09/2020
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
09/2020
1Sirolimus (Rapamycin)FDA Link
09/2020
1N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA
01/2020
1amidaseIBA
01/2020
1Peptidoglycan (Murein)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Untranslated RNA (Noncoding RNA)IBA
01/2019
1AntigensIBA
01/2019
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2018
1histone H3 trimethyl Lys4IBA
01/2018
1LigandsIBA
01/2017
1Heparin Lyase (heparin lyase)IBA
01/2017
1AZD4547IBA
01/2017
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2017
1Tyrosine (L-Tyrosine)FDA Link
01/2017
1RiboswitchIBA
11/2016
1VaccinesIBA
10/2013
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2012
1Tetracycline (Achromycin)FDA LinkGeneric
12/2011
1Peptide Hydrolases (Proteases)FDA Link
12/2011
1InterferonsIBA
12/2011
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
02/2010
1estropipate (Ogen)FDA LinkGeneric
08/2009
1Estrogen ReceptorsIBA
08/2009
1Fibrinogen (Factor I)FDA Link
08/2009
1Cadherins (E-Cadherin)IBA
08/2009
1cadherin 5IBA
08/2009
1Platelet-Derived Growth FactorIBA
01/2009
1Phosphotransferases (Kinase)IBA
07/2007
1DNA (Deoxyribonucleic Acid)IBA
07/2007
1NF-kappa B (NF-kB)IBA
07/2007
1ProstaglandinsIBA
09/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2006
1Interleukin-1 (Interleukin 1)IBA
07/2004
1Cycloheximide (Cicloheximide)IBA
08/2002
1Protein Synthesis InhibitorsIBA
08/2002

Therapy/Procedure

1Therapeutics
01/2017